VyCAP was founded in 2011 as a spin-off company from the University of Twente. We offer solutions to enumerate, isolate and analyze rare single cells from humans and xenografts. Our products are used in laboratories around the world working on circulating tumor cells, tumor model systems, organoids and circulating fetal cells.
Vision and mission
VyCAP designs and markets practical and affordable solutions that are based on the latest (bio)technologies that aid in understanding of biological process at the single cell level.